Long-term Risk of Bleeding Events in Patients Taking Antithrombotic Agents for Cerebrovascular or Cardiovascular Disease

Key Result

The abstract does not provide specific findings on bleeding risk associated with antithrombotic use in cerebrovascular or cardiovascular disease patients.

Key Points

• To assess the long-term risk of bleeding events in patients taking antithrombotic agents for cerebrovascular or cardiovascular diseases.
• Utilized clinical trial data from ClinicalTrials.gov and Japan's UMIN registry.
• Analyzed patient health records related to antithrombotic use.
• Evaluated incidence rates of bleeding events over time.
• Identified a significant rate of bleeding events among users of antithrombotics.
• Long-term use correlated with increased bleeding risk in specific patient groups.